Engimmune Therapeutics raises CHF15.5m in...Cancer specialist Engimmune Therapeutics has raised CHF15.5m in a seed financing to expand its pipeline of T-cell receptor therapeutics. more ➔
Switzerland shows sustained growth of biot...The Swiss Biotech sector has again attracted record-breaking investments in 2021, according to the Swiss Biotech Report that was presented at the Swiss Biotech Day 2022 in Basel. more ➔
Commission to establish EU health data spa...Digital medicine holds great opportunities. The EU Commission is therefore presenting a draft law this week that defines rules for a European Health Data Space. more ➔
Four new autoantigens trigger multiple scl...Swiss and Swedish researchers have uncovered four previously unkown autoantigens that trigger multiple sclerosis in mice. more ➔
TWB partners with Processium and SyngulonIndustrial biotech project managment specialist Toulouse White Biotech (TWB) has joined forces with process developer Processium and industrial synbio start-up Syngulon. more ➔
Meat consumption must fall by at least 75...If our planet is to continue feeding us in the future, rich countries must significantly reduce their meat consumption by at least 75% suggests a new study by German researchers. more ➔
Vigeneron updates gene therapy collab with...ViGeneron and Daiichi Sankyo have agreed a follow-on collaboration to evaluate vgAAVs as vectors for Daiichi Sankyo novel treatment of prevalent eye diseases. more ➔
Single-use market to reach $20.8bn by 2026 Analysts from Markets & Markets today released the report "Single use Bioprocessing Market by Product. more ➔
Study shows advantages of cellular agricul...Novel foods derived from cell culture instead of animals reduce the environmental impact of diets, water and land use by 80%, report Finnish researchers. more ➔
EMA delays Valneva vaccine approvalThe approval of Valneva’s Corona vaccine is delaying. The European Medicines Agencys CHMP requested additional data. more ➔
